On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
psychedelic drugs
.
Show all posts
Showing posts with label
psychedelic drugs
.
Show all posts
Thursday, June 26, 2025
Low-Dose Active-Control Trials in Psychedelic and CNS Drug Development
›
This week, Compass Pathways plc (Nasdaq: CMPS) announced the successful achievement of the primary endpoint in the ongoing Phase 3 COMP005 t...
›
Home
View web version